Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Travel Medicine|January 7, 2012
Latitudinal patterns of travel among returned travelers with influenza: results from the GeoSentinel Surveillance Network, 1997-2007Andrea K Boggild, Francesco Castelli, Philippe Gautret, et al.
Vaccine|September 21, 2010
Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance NetworkAndrea K Boggild, Francesco Castelli, Philippe Gautret, et al.
Communicable Diseases Intelligence Quarterly Report|March 10, 2017
Arboviral diseases and malaria in Australia, 2013-14: Annual report of the National Arbovirus and Malaria Advisory CommitteeKatrina E Knope, Mike Muller, Nina Kurucz, et al.
Vaccine|June 30, 2023
Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in miceJulio Carrera, Turgut E Aktepe, Linda Earnest, et al.
Biotechnology and Bioengineering|February 12, 2025
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at ScaleMelissa A Edeling, Linda Earnest, Julio Carrera Montoya, et al.
Communicable Diseases Intelligence Quarterly Report|April 16, 2016
Arboviral diseases and malaria in Australia, 2012-13: Annual report of the National Arbovirus and Malaria Advisory CommitteeKatrina E Knope, Nina Kurucz, Stephen L Doggett, et al.
The Australian Journal of Rural Health|July 27, 2019
Epidemiology of melanoma in rural southern QueenslandScott Kitchener, Janani Pinidiyapathirage, Keegan Hunter, et al.
Emerging Infectious Diseases|June 15, 2013
Travel-associated illness trends and clusters, 2000-2010Karin Leder, Joseph Torresi, John S Brownstein, et al.
Human Vaccines|October 3, 2006
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypesFarshad Guirakhoo, Scott Kitchener, Dennis Morrison, et al.
The Journal of General Virology|May 6, 2016
Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell lineL Earnest-Silveira, B Chua, R Chin, et al.
Pageof 16